New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - verapamil hydrochloride 40mg;   - film coated tablet - 40 mg - active: verapamil hydrochloride 40mg   excipient: acacia calcium carbonate carmellose sodium colloidal silicon dioxide   glycol montanate calcium arachinate lactose monohydrate maize starch   potato starch povidone purified talc   purified water quinoline yellow sucrose titanium dioxide

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - modified release tablets,isoptin sr is indicated for the management of hypertension and angina pectoris.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - verapamil hydrochloride - tablet, film coated - 240 mg - verapamil hydrochloride 240.0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 4 mg; verapamil hydrochloride, quantity: 240 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; povidone; hypromellose; sodium stearylfumarate; microcrystalline cellulose; sodium alginate; magnesium stearate; hyprolose; macrogol 400; macrogol 6000; purified talc; colloidal anhydrous silica; titanium dioxide; iron oxide red; iron oxide yellow; iron oxide black; docusate sodium - tarka is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 40 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 80 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 120 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - verapamil hydrochloride 240mg - modified release tablet - 240 mg - active: verapamil hydrochloride 240mg excipient: l-green lake zlt 601 glycol montanate hypromellose macrogol 400 macrogol 6000 magnesium stearate microcrystalline cellulose povidone purified talc purified water sodium alginate titanium dioxide - · angina pectoris - for the prophylaxis and treatment of coronary insufficiency: chronic stable angina pectoris; angina at rest including vasospastic (prinzmetal's, variant angina) and unstable angina (crescendo, pre-infarction angina); angina pectoris post myocardial infarction.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ireland limited - verapamil hydrochloride - film-coated tablets - 80mg - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-
angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).
supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).
mild to moderate essential hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 2 mg; verapamil hydrochloride, quantity: 180 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; povidone; hypromellose; sodium stearylfumarate; microcrystalline cellulose; sodium alginate; magnesium stearate; hyprolose; macrogol 400; macrogol 6000; purified talc; colloidal anhydrous silica; titanium dioxide; iron oxide red; iron oxide yellow; iron oxide black; docusate sodium - tarka is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.